Intended for healthcare professionals


US officials threaten to sanction firm that promised to revolutionize blood testing

BMJ 2016; 353 doi: (Published 15 April 2016) Cite this as: BMJ 2016;353:i2189
  1. Michael McCarthy
  1. Seattle

US regulators have proposed revoking the federal license of the California laboratory of the biotechnology firm Theranos and banning the company’s top officials from owning or running a laboratory for at least two years.

The privately held company had promised to revolutionize the blood testing industry with a technology that the company said made it possible to run various tests for a wide variety of conditions from only few drops of blood collected with a simple finger prick. With the claim that its technology would make blood testing faster, cheaper, less painful, and more …

View Full Text

Log in

Log in through your institution


* For online subscription